Displaying 25 - 32 of 32
Immune-Mediated and Cholestatic Diseases
5

CymaBay Therapeutics: "Resetting the ideal goals of PBC treatment: A case – based discussion"  - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
6

Mirum Pharmaceuticals, Inc: "Not just an itch: The burden of PBC and PSC" - EASL Congress 2023

View
Immune-Mediated and Cholestatic Diseases
1

BioMarin: Gene therapy clinical trials for haemophilia: A partnership between haematologists and hepatologists - ILC 2022

View
Displaying 25 - 32 of 32